202 related articles for article (PubMed ID: 25028518)
1. Inactivation of the Mycobacterium tuberculosis antigen 85 complex by covalent, allosteric inhibitors.
Favrot L; Lajiness DH; Ronning DR
J Biol Chem; 2014 Sep; 289(36):25031-40. PubMed ID: 25028518
[TBL] [Abstract][Full Text] [Related]
2. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen.
Favrot L; Grzegorzewicz AE; Lajiness DH; Marvin RK; Boucau J; Isailovic D; Jackson M; Ronning DR
Nat Commun; 2013; 4():2748. PubMed ID: 24193546
[TBL] [Abstract][Full Text] [Related]
4. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
5. Mycolyltransferase from
Goins CM; Dajnowicz S; Smith MD; Parks JM; Ronning DR
J Biol Chem; 2018 Mar; 293(10):3651-3662. PubMed ID: 29352107
[No Abstract] [Full Text] [Related]
6. Targeting the Mycobacterium tuberculosis transpeptidase Ldt
de Munnik M; Lohans CT; Lang PA; Langley GW; Malla TR; Tumber A; Schofield CJ; Brem J
Chem Commun (Camb); 2019 Aug; 55(69):10214-10217. PubMed ID: 31380528
[TBL] [Abstract][Full Text] [Related]
7. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.
Ronning DR; Klabunde T; Besra GS; Vissa VD; Belisle JT; Sacchettini JC
Nat Struct Biol; 2000 Feb; 7(2):141-6. PubMed ID: 10655617
[TBL] [Abstract][Full Text] [Related]
9. Ebselen Reversibly Inhibits Human Glutamate Dehydrogenase at the Catalytic Site.
Jin Y; Li D; Lu S; Zhao H; Chen Z; Hou W; Ruan BH
Assay Drug Dev Technol; 2018; 16(2):115-122. PubMed ID: 29470101
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and X-ray analysis of a glycoconjugate bound to Mycobacterium tuberculosis antigen 85C.
Ibrahim DA; Boucau J; Lajiness DH; Veleti SK; Trabbic KR; Adams SS; Ronning DR; Sucheck SJ
Bioconjug Chem; 2012 Dec; 23(12):2403-16. PubMed ID: 23190459
[TBL] [Abstract][Full Text] [Related]
11. Functional insights from a comparative study on the dynamics of Antigen85 proteins and MPT51 from Mycobacterium tuberculosis.
Sundar S; Annaraj D; Selvan A; Biswas PG; Vijayakumaran R; Anishetty S
J Mol Model; 2015 Dec; 21(12):310. PubMed ID: 26564147
[TBL] [Abstract][Full Text] [Related]
12. The structure of Mycobacterium tuberculosis MPT51 (FbpC1) defines a new family of non-catalytic alpha/beta hydrolases.
Wilson RA; Maughan WN; Kremer L; Besra GS; Fütterer K
J Mol Biol; 2004 Jan; 335(2):519-30. PubMed ID: 14672660
[TBL] [Abstract][Full Text] [Related]
13. The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions.
Backus KM; Dolan MA; Barry CS; Joe M; McPhie P; Boshoff HI; Lowary TL; Davis BG; Barry CE
J Biol Chem; 2014 Sep; 289(36):25041-53. PubMed ID: 25028517
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into Mycobacterium antigen Ag85 biology and implications in countermeasures for M. tuberculosis.
Tang X; Deng W; Xie J
Crit Rev Eukaryot Gene Expr; 2012; 22(3):179-87. PubMed ID: 23140159
[TBL] [Abstract][Full Text] [Related]
15. Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.
Warrier T; Tropis M; Werngren J; Diehl A; Gengenbacher M; Schlegel B; Schade M; Oschkinat H; Daffe M; Hoffner S; Eddine AN; Kaufmann SH
Antimicrob Agents Chemother; 2012 Apr; 56(4):1735-43. PubMed ID: 22290959
[TBL] [Abstract][Full Text] [Related]
16. Weak spots inhibition in the
Adewumi AT; Elrashedy A; Soremekun OS; Ajadi MB; Soliman MES
J Biomol Struct Dyn; 2022 Apr; 40(7):2934-2954. PubMed ID: 33155529
[No Abstract] [Full Text] [Related]
17. Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex.
Kuo CJ; Ptak CP; Hsieh CL; Akey BL; Chang YF
J Biol Chem; 2013 Feb; 288(6):3886-96. PubMed ID: 23250738
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of chalcone synthase. pKa of the catalytic cysteine and the role of the conserved histidine in a plant polyketide synthase.
Jez JM; Noel JP
J Biol Chem; 2000 Dec; 275(50):39640-6. PubMed ID: 11006298
[TBL] [Abstract][Full Text] [Related]
20. Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives.
Amporndanai K; Meng X; Shang W; Jin Z; Rogers M; Zhao Y; Rao Z; Liu ZJ; Yang H; Zhang L; O'Neill PM; Samar Hasnain S
Nat Commun; 2021 May; 12(1):3061. PubMed ID: 34031399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]